Search Results - "To, Ramsey"

Autocrine C‐peptide protects INS1 β cells against palmitic acid‐induced oxidative stress in peroxisomes by inducing catalase by Luppi, Patrizia, Drain, Nicholas, To, Ramsey, Stolz, Donna, Wallace, Callen, Watkins, Simon, Drain, Peter

“…Aims C‐peptide, produced by pancreatic β cells and co‐secreted in the bloodstream with insulin, has antioxidant properties in glucose‐ and hydrogen peroxide…”
Get full text

Vascularized Bone Graft Reconstruction for Upper Extremity Defects: A Review by Ava G. Chappell, Matthew D. Ramsey, Parinaz J. Dabestani, Jason H. Ko

“…Upper extremity reconstruction may pose clinical challenges for surgeons due to the often-critical, complex functional demands of the damaged and/or missing…”
Get full text

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach by Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen

“…Background/Aims: Due to increases in obesity and type 2 diabetes, the prevalence of nonalcoholic fatty liver disease (NAFLD) has also been increasing. Current…”
Get full text

Global incidence of adverse clinical events in nonalcoholic fatty liver disease: A systematic review and meta-analysis by Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, Keeseok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen

“…Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with a multitude of adverse outcomes. We aimed to estimate the pooled incidence of…”
Get full text

Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study by Vy H. Nguyen, Isaac Le, Audrey Ha, Richard Hieu Le, Nicholas Ajit Rouillard, Ashley Fong, Surya Gudapati, Jung Eun Park, Mayumi Maeda, Scott Barnett, Ramsey Cheung, Mindie H. Nguyen

“…Background/Aims: Understanding of nonalcoholic fatty liver disease (NAFLD) continues to expand, but the relationship between race and ethnicity and NAFLD…”
Get full text

Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data metaanalysis by Yu Jun Wong, Vy H. Nguyen, Hwai-i Yang, Jie Li, Michael Huan Le, Wan-jung Wu, Nicole Xinrong Han, Khi Yung Fong, Elizabeth Chen, Connie Wong, Fajuan Rui, Xiaoming Xu, Qi Xue, Xin Yu Hu, Wei Qiang Leow, George Boon-bee Goh, Ramsey Cheung, Grace Wong, Vincent Wai-sun Wong, Ming-whei Yu, Mindie H. Nguyen

“…Background/Aims: Chronic hepatitis B (CHB) and fatty liver (FL) often co-exist, but natural history data of this dual condition (CHB-FL) are sparse. Via a…”
Get full text

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis by Hyo Young Lee, Dae Won Jun, Hyun Jung Kim, Hyunwoo Oh, Waqar Khalid Saeed, Hyeongsik Ahn, Ramsey C. Cheung, Mindie H. Nguyen

“…Background/Aims: A number of clinical trials reported varying effects of cho-lesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We,…”
Get full text